MaaT Pharma Investor Relations Material

MaaT Pharma SA is a biotechnology company specializing in the development of microbiome-based therapies for the treatment of diseases related to immune and gastrointestinal disorders. The company focuses on restoring gut microbiota balance to support patient health, particularly in areas such as oncology and infectious diseases. MaaT Pharma utilizes a proprietary research platform to develop therapeutic solutions, including biotherapeutic products derived from microbiota. The company is engaged in clinical research and collaborates with healthcare institutions and industry partners to advance its pipeline. MaaT Pharma is headquartered in Lyon, France, and its shares are listed on the Euronext.